{"gene":"BACH2","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":1998,"finding":"BACH2 was identified as a B-cell-specific transcription factor that forms heterodimers with small Maf proteins (e.g., MafK) and binds to Maf recognition elements (MAREs) in the IgH 3' enhancer, acting as a negative regulator. BACH2 also binds the co-repressor SMRT.","method":"Co-immunoprecipitation, EMSA, B-cell extract binding assays, reporter assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (EMSA, pulldown, reporter assays) in foundational paper; widely replicated","pmids":["9755173"],"is_preprint":false},{"year":2000,"finding":"BACH2 is regulated by oxidative stress-sensitive conditional nuclear export via a C-terminal cytoplasmic localization signal (CLS) that directs leptomycin B-sensitive (CRM1/exportin-1-dependent) nuclear export. Oxidative stressors abrogate this CLS activity, causing nuclear accumulation of BACH2 and repression of MARE-dependent transcription.","method":"Mutagenesis, leptomycin B treatment, fluorescence microscopy, reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis of CLS combined with pharmacological inhibition and reporter assays; replicated by subsequent studies","pmids":["10809773"],"is_preprint":false},{"year":2002,"finding":"Upon oxidative stress, BACH2 forms nuclear foci associated with PML nuclear bodies and promotes apoptosis. BACH2 acts as a generic repressor of TRE-, MARE-, and ARE-driven transcription, and its nuclear accumulation upon oxidative stress is required but not sufficient for apoptosis induction.","method":"Retroviral bicistronic reporter, fluorescence microscopy, apoptosis assays, immunofluorescence co-localization with PML bodies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — single lab but multiple orthogonal methods; specificity demonstrated by comparison with Bach1","pmids":["11923289"],"is_preprint":false},{"year":2004,"finding":"BACH2 is required for class switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin genes in activated B cells. Genetic ablation of Bach2 in mice shows it is not required for plasma cell differentiation per se but is essential for the CSR process.","method":"Bach2 knockout mice, in vitro B-cell stimulation, immunoglobulin analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple immunological readouts; highly cited foundational paper","pmids":["15152264"],"is_preprint":false},{"year":2004,"finding":"Upon oxidative stress, BACH2 is sumoylated, which is required for its recruitment around PML nuclear bodies. BACH2 selectively represses transcription associated with PML bodies; FRAP experiments revealed rapid turnover of BACH2 in nuclear foci, and the BTB domain is essential for focus formation.","method":"Fluorescence recovery after photobleaching (FRAP), mutagenesis, sumoylation assays, reporter gene assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — FRAP, mutagenesis, and functional reporter assays in single rigorous paper","pmids":["15060166"],"is_preprint":false},{"year":2006,"finding":"BACH2 directly represses expression of Blimp-1 (encoded by Prdm1) in B cells by binding as a heterodimer with MafK to the MARE upstream of the Prdm1 promoter and in intron 5. Loss of BACH2 leads to more rapid and robust Blimp-1 induction and plasma cell differentiation.","method":"EMSA, ChIP, reporter assays, shRNA knockdown, primary Bach2-deficient B cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including EMSA, ChIP, and functional assays; replicated across labs","pmids":["17046816"],"is_preprint":false},{"year":2006,"finding":"BCR/ABL signaling phosphorylates BACH2 at S521 via the PI3K/S6 kinase pathway, which promotes cytoplasmic retention of BACH2 and prevents nuclear accumulation. Mutation of S521 to alanine leads to nuclear accumulation and greater growth inhibition of CML cells.","method":"Mutagenesis, phosphorylation assays, subcellular fractionation, cell growth assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — site-directed mutagenesis combined with functional localization studies","pmids":["17018862"],"is_preprint":false},{"year":2007,"finding":"SMRT co-repressor mediates HDAC4 binding to BACH2; HDAC4 facilitates retention of BACH2 in nuclear foci. Co-expression of SMRT and HDAC4 enhances BACH2 nuclear focus formation and local transcriptional repression at MARE-containing reporter genes.","method":"Co-immunoprecipitation, confocal microscopy, scratch transcription labeling, reporter assays","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP and functional assays in single lab; mechanistic detail limited to one paper","pmids":["17383980"],"is_preprint":false},{"year":2008,"finding":"BACH2 interacts with BCL6 in B cells in a BTB-domain-independent manner. Both BACH2 and BCL6 bind to separate regulatory elements (MARE and BCL6-binding element, respectively) of the Prdm1 gene and cooperate to repress its expression; co-expression results in greater repression.","method":"Co-immunoprecipitation, ChIP, reporter assays","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP and ChIP in single lab with functional reporter validation","pmids":["18256039"],"is_preprint":false},{"year":2010,"finding":"BACH2 represses Blimp-1 in B cells to create a time delay in plasma cell differentiation, allowing a window for class switch recombination. Genetic loss of Blimp-1 in Bach2-/- B cells restores CSR, establishing that Bach2 acts upstream of Blimp-1 in the B-cell gene regulatory network.","method":"Double-knockout mouse genetics, mathematical modeling of GRN, in vitro B-cell stimulation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via double-KO mice; replicated and mechanistically validated","pmids":["20953163"],"is_preprint":false},{"year":2011,"finding":"Heme binds to BACH2 and inhibits its DNA-binding activity in vitro; heme also reduces BACH2 half-life in B cells. Heme treatment of B cells enhances Blimp-1 transcription and skews plasma cell differentiation toward IgM. Heme oxygenase-1 is repressed by both BACH2 and BACH1 in B cells.","method":"In vitro DNA-binding assay, pulse-chase protein stability assay, B-cell culture with heme treatment, reporter assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro biochemical assay plus cellular functional validation; replicated in structural study","pmids":["21444915"],"is_preprint":false},{"year":2011,"finding":"Crystal structure of the human BACH2 POZ/BTB domain dimer was solved at 2.1 Å resolution. The structure reveals an intersubunit disulfide bond present both in bacterially expressed protein and in eukaryotic cells. The BTB domain mediates dimerization and recruits co-repressors including class II HDACs.","method":"X-ray crystallography, biochemical validation in solution and in transfected eukaryotic cells","journal":"Acta crystallographica. Section D, Biological crystallography","confidence":"High","confidence_rationale":"Tier 1 — crystal structure at 2.1 Å with biochemical validation","pmids":["22194330"],"is_preprint":false},{"year":2013,"finding":"BACH2 broadly represses effector CD4+ T-cell differentiation programs (Th1, Th2, Th17) while being required for efficient Foxp3+ Treg cell formation. In Bach2-deficient mice, Treg polarization results in inappropriate diversion to effector lineages, and lethal inflammation is suppressed in a Treg-dependent manner. Genome-wide BACH2 occupancy showed enrichment at enhancers of effector differentiation genes.","method":"Bach2 knockout mice, ChIP-seq, genome-wide expression profiling, Treg transfer experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — KO mice with ChIP-seq and multiple cellular phenotypic readouts; highly cited and widely replicated","pmids":["23728300"],"is_preprint":false},{"year":2013,"finding":"BACH2 activates p53 to mediate negative selection of pre-B cells that fail productive VH-DJH rearrangement. Pre-BCR signaling ends BACH2-mediated negative selection via BCL6-mediated repression of p53. BACH2 competes with BCL6 for promoter binding and reverses BCL6-mediated repression of p53 and cell cycle checkpoint genes.","method":"ChIP-seq, gene expression analysis, Bach2 knockout pre-B cells, leukemia transplant experiments","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq plus genetic epistasis and functional in vivo assays","pmids":["23852341"],"is_preprint":false},{"year":2013,"finding":"BACH2 maintains naive T cells by suppressing effector-memory-related genes including CCR4, ST-2, and Blimp-1. ChIP-seq identified direct BACH2 target genes (S100 calcium binding protein a, Heme oxygenase-1, prolyl hydroxylase 3). Forced expression of BACH2 restored expression of these genes.","method":"ChIP-seq, Bach2-deficient mouse T-cell analysis, forced expression experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq with genetic KO and forced expression rescue","pmids":["23754397"],"is_preprint":false},{"year":2013,"finding":"Antigen-experienced IgG1 memory B cells have repressed Bach2 expression compared to non-experienced IgG1 B cells, and this Bach2 repression contributes to predisposition toward plasma cell differentiation upon rechallenge.","method":"Engineered mice with non-experienced IgG1 B cells, gene expression analysis, in vivo rechallenge experiments","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 — genetic mouse model with mechanistic link between Bach2 repression and cell fate; single lab","pmids":["23850379"],"is_preprint":false},{"year":2013,"finding":"Bach2 cooperates with BCL6 in germinal center B cells to repress the plasma cell program. BCL6 and BACH2 bind overlapping sets of target genes (~30% peak overlap), including PRDM1 cis-regulatory sequences. BACH2 binds predominantly with heterodimer partner MAFK. BCL6 also modulates BACH2 protein stability, and their levels are positively correlated in GC B cells.","method":"ChIP-seq, double-heterozygous knockout mice, protein stability assays, B-cell gene expression profiling","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq combined with double-heterozygous genetic model and biochemical stability assays","pmids":["24277074"],"is_preprint":false},{"year":2013,"finding":"BACH2 promotes Foxp3 expression in a TCR/TGF-β-induced Treg differentiation assay and represses the competing Gata3-driven Th2 effector program. Bach2-deficient Treg cells show reduced Bcl-2 and Mcl-1 levels and elevated Bim/Bcl-2 ratio, contributing to reduced survival.","method":"Bach2 KO mouse, in vitro Treg induction assay, flow cytometry, gene expression analysis","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"Medium","confidence_rationale":"Tier 2 — KO mice with mechanistic in vitro rescue experiments; single lab","pmids":["24367030"],"is_preprint":false},{"year":2014,"finding":"BACH2 represses myeloid genes in B-cell progenitors (common lymphoid progenitors) to promote B-cell lineage commitment. Bach2 and Bach1 bind presumptive regulatory regions of myeloid genes. Bach2-high CLPs are resistant to myeloid differentiation even under myeloid culture conditions.","method":"Bach2/Bach1 KO mice, single-cell analysis of CLPs, ChIP, overexpression in pre-pro-B cells lacking EBF1","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — KO mice, single-cell analysis, and ChIP with functional differentiation assays","pmids":["25344725"],"is_preprint":false},{"year":2014,"finding":"Menin binds to the Bach2 locus and controls its expression through maintenance of histone acetylation. T cell-specific Menin deficiency results in decreased Bach2 expression and premature CD4+ T cell senescence; this Menin-Bach2 axis regulates cytokine homeostasis.","method":"T cell-specific Menin conditional KO mice, ChIP at Bach2 locus, histone acetylation analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating Menin binding at Bach2 locus with conditional KO phenotypic validation","pmids":["24694524"],"is_preprint":false},{"year":2014,"finding":"Heme binds to an intrinsically disordered region (residues 331–520) of BACH2 containing Cys-Pro motifs. Heme binding is in 5- and 6-coordinated modes, induces conformational changes (revealed by CD, SAXS, DLS), and alters protein interactions mediated by this region. The CP-motif mutant lacks 5-coordinated heme binding.","method":"Spectroscopic analysis (UV-Vis, CD), dynamic light scattering, small-angle X-ray scattering, chemical modification, GAL4-based luciferase assay","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 — multiple biophysical methods defining heme-binding domain and conformational changes","pmids":["25444856"],"is_preprint":false},{"year":2015,"finding":"Bach2 is phosphorylated at multiple sites in B cells via the PI3K-Akt-mTOR pathway. The mTOR complex 1 (mTORC1) phosphorylates Bach2 in vitro. A single phosphorylation site, Ser-535 (murine), is critical: the Ser-535 mutation abolishes cytoplasmic accumulation and promotes nuclear localization, enhancing Bach2 repressor activity.","method":"Mass spectrometry phosphosite identification, kinase inhibitors, mTORC1 in vitro phosphorylation assay, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay, mass spectrometry, and mutagenesis identifying critical phosphorylation site","pmids":["26620562"],"is_preprint":false},{"year":2016,"finding":"BACH2 is recruited to enhancers in naive CD8+ T cells, where it limits expression of TCR-driven effector genes by attenuating AP-1 site availability to Jun family signal-dependent transcription factors. Upon effector differentiation, reduced BACH2 expression and its phosphorylation enable unrestrained TCR-driven effector programs.","method":"ChIP-seq, ATAC-seq, BACH2 KO mouse, viral infection models","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq and ATAC-seq combined with genetic KO; highly cited","pmids":["27158840"],"is_preprint":false},{"year":2016,"finding":"Bach2 associates with Batf and together the Bach2-Batf complex binds to regulatory regions of Th2 cytokine gene loci. This complex antagonizes the Batf-Irf4 complex at AP-1 motifs, suppressing Th2 cytokine production. Bach2 also regulates Batf/Batf3 expression by inhibiting IL-4 production and directly repressing Batf/Batf3 gene loci.","method":"Co-immunoprecipitation, ChIP-seq, Bach2 KO mouse, cytokine measurement assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — Co-IP, ChIP-seq, and genetic KO with functional cytokine readouts","pmids":["27581382"],"is_preprint":false},{"year":2016,"finding":"BACH2 haploinsufficiency causes a syndrome of immunodeficiency and autoimmunity (BRIDA). BACH2 mutations disrupt protein stability by interfering with homodimerization or causing aggregation. BACH2 is associated with a super-enhancer architecture, and SE-associated gene haploinsufficiency is enriched among Mendelian immunodeficiency diseases.","method":"Human genetics, patient cell studies, protein stability assays, homodimerization assays, SE chromatin analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — functional protein studies combined with human disease genetics; orthologous mouse findings","pmids":["28530713"],"is_preprint":false},{"year":2016,"finding":"BACH2 promotes tumor immunosuppression through Treg-mediated inhibition of intratumoral CD8+ T cells and IFN-γ. In Bach2-deficient mice, tumor growth is markedly impaired, with high frequencies of rapidly proliferating effector T cells and reduced intratumoral Foxp3+ Tregs.","method":"Bach2 KO mouse tumor implantation models, adoptive transfer experiments, intratumoral lymphocyte analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO experiments with mechanistic T cell transfer studies","pmids":["26731475"],"is_preprint":false},{"year":2016,"finding":"The epigenetic regulation of Prdm1 in B cells involves BACH2 interacting with HDAC3-containing co-repressor complexes (including NCoR1, NCoR2, Tbl1x, and Rif1) to write histone deacetylation marks at the Prdm1 intron 5 MARE. ChIP confirmed binding of HDAC3 and Rif1 to the Prdm1 locus; knockdown of HDAC3 or NCoR1 increased Prdm1 expression.","method":"Purification of Bach2 complex by mass spectrometry, ChIP, RNA interference knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — complex purification by MS, ChIP, and functional RNAi in same study","pmids":["26786103"],"is_preprint":false},{"year":2017,"finding":"mTOR complex 1 (mTORC1) inhibits nuclear accumulation and stability of Bach2, while mTOR complex 2 (mTORC2) inhibits FoxO1 to reduce Bach2 mRNA expression. Bach2 directly regulates Ccnd3 (cyclin D3) expression. The mTOR-Bach2 cascade controls proper cell cycle arrest in B cells, and mTOR inhibition enhances CSR in a Bach2-dependent manner.","method":"mTOR inhibitor treatment, Bach2 KO mice, ChIP, expression profiling, cell cycle analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — ChIP identifying direct target plus pharmacological-genetic epistasis; multiple orthogonal approaches","pmids":["28993481"],"is_preprint":false},{"year":2017,"finding":"Bach2 and C/EBPβ form a mutual repression gene regulatory network in multipotent hematopoietic progenitors. Bach2 represses Cebpb and Csf1r; C/EBPβ represses Bach2 and activates Csf1r. Both factors bind overlapping regulatory regions at myeloid target genes. LPS reduces Bach2 expression, enhancing myeloid differentiation.","method":"ChIP, gene expression profiling, KO mouse models, LPS stimulation experiments","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP with genetic KO models and LPS functional challenge","pmids":["28273455"],"is_preprint":false},{"year":2017,"finding":"IL-2 drives BACH2 repression via ERK/ELK1 signaling to direct plasma cell lineage commitment in human naive B cells. Enforced BACH2 repression unlocks the plasma cell transcriptional program. An active regulatory region within the BACH2 super-enhancer is under ELK1 control.","method":"RNA-seq, ChIP-seq, ERK/ELK1 inhibitors, B-cell differentiation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — RNA-seq and ChIP-seq combined with functional pathway inhibition; human cells","pmids":["29129929"],"is_preprint":false},{"year":2018,"finding":"SENP3-mediated deSUMOylation of BACH2 prevents its nuclear export, thereby repressing effector T-cell differentiation genes and stabilizing Treg cell-specific gene signatures. Treg-specific deletion of Senp3 results in T-cell activation and autoimmune symptoms. ROS accumulation promotes SENP3 accumulation in Treg cells involved in tumor immunosuppression.","method":"Treg-specific Senp3 conditional KO mice, SUMOylation assays, subcellular fractionation, ChIP, tumor immunosuppression models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — conditional KO combined with biochemical SUMOylation assays and localization studies","pmids":["30089837"],"is_preprint":false},{"year":2018,"finding":"Bach2 and Bach1 promote erythroid commitment by repressing the myeloid transcription factor gene Cebpb and its targets at the erythro-myeloid bifurcation step. Bach TFs bind to regulatory regions co-occupied by C/EBPβ. Knockdown of BACH1 or BACH2 in human CD34+ HSPCs impairs erythroid differentiation in vitro.","method":"ChIP, Bach2/Bach1 KO and overexpression in HSPCs, human CD34+ siRNA knockdown, erythroid differentiation assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus genetic KO/OE and human cell knockdown with differentiation phenotype","pmids":["30250186"],"is_preprint":false},{"year":2019,"finding":"Bach2 directly suppresses Bcl-6 transcription in Tfh cells by binding to the Bcl-6 promoter and replacing an activating Batf-Irf4 complex, thereby controlling the Tfh cell transcriptional network. This is mechanistically distinct from GC B cells, where Bach2 and Bcl-6 are co-expressed.","method":"Ectopic overexpression in murine Tfh cells, reporter assays, ChIP at Bcl-6 promoter","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"Medium","confidence_rationale":"Tier 2–3 — ChIP and functional reporter in overexpression model; mechanistic detail from single lab","pmids":["30833348"],"is_preprint":false},{"year":2019,"finding":"Bach2 directly suppresses CXCR5 and c-Maf expression in CD4+ T cells by binding to a regulatory element in the CXCR5 locus. Bach2 deficiency results in preferential Tfh cell differentiation but ultimately collapsed CD4+ T cell memory.","method":"Bach2 KO mouse, identification of novel CXCR5 regulatory element by reporter assay, in vivo viral infection models","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct binding to CXCR5 regulatory element combined with in vivo KO phenotype","pmids":["30971440"],"is_preprint":false},{"year":2020,"finding":"BACH2 in resting Treg cells binds to enhancers of genes involved in activated Treg differentiation and represses their TCR-driven induction by competing with AP-1 factors for DNA binding, thereby maintaining Treg quiescence.","method":"Bach2 conditional KO in Tregs, ChIP-seq, ATAC-seq, tumor immunosuppression models","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq and ATAC-seq combined with conditional KO and AP-1 competition mechanistic evidence","pmids":["32515782"],"is_preprint":false},{"year":2020,"finding":"BACH2 counteracts the DNA-binding activity of IRF4 and limits chromatin accessibility, thereby attenuating IRF4-dependent transcription in Treg cells. Loss of Bach2 normalizes eTreg differentiation of IRF4-deficient Tregs, establishing genetic epistasis between BACH2 and IRF4.","method":"Bach2/IRF4 double conditional KO epistasis experiments, ATAC-seq, ChIP-seq","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double KO combined with chromatin accessibility profiling","pmids":["31937752"],"is_preprint":false},{"year":2021,"finding":"BACH2 establishes the transcriptional and epigenetic programs of stem-like CD8+ T cells during chronic infection; BACH2 overexpression enforces stem-like cell fate while BACH2 deficiency impairs stem-like CD8+ T cell differentiation. BACH2 suppresses the terminal exhaustion program through transcriptional repression and epigenetic silencing.","method":"BACH2 KO, overexpression, single-cell transcriptomics, single-cell epigenomics (scATAC-seq), chronic viral infection models","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — single-cell multi-omic approaches combined with KO and overexpression in vivo","pmids":["33574619"],"is_preprint":false},{"year":2021,"finding":"BACH2 directly represses CD25 (IL-2Rα) transcription in Treg cells, thereby attenuating IL-2R signaling. Upregulated CD25/IL-2R signaling in Bach2-deficient resting Tregs partially counteracts poor survival. Bach2 also suppresses CD25/IL-2R signaling in T follicular regulatory cells to enable their full differentiation.","method":"Bach2 conditional KO in Tregs, ChIP at CD25 locus, flow cytometry, in vivo Tfr analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating direct BACH2 repression of CD25 combined with conditional KO functional data","pmids":["33979619"],"is_preprint":false},{"year":2021,"finding":"BACH2 knockdown in T2D pancreatic islets reverses cellular features of the disease, restoring a non-diabetic phenotype. BACH2 is identified as a master regulator of T2D islet cell states via single-cell gain- and loss-of-function analyses and glucose-induced Ca2+ flux assays.","method":"Single-cell gain/loss-of-function, Ca2+ flux assays, BACH2 KO in T2D islets, BACH inhibitor treatment in diabetic mice and human islets","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in primary human islets and mouse models; single lab","pmids":["34907913"],"is_preprint":false},{"year":2022,"finding":"BACH2 acts as an intrinsic negative regulator of NK cell maturation and function by restricting maturation in the presence of weak stimulatory signals. BACH2 expression positively correlates with TCF1 and negatively correlates with NK effector molecules; lack of BACH2 causes changes in chromatin accessibility and accumulation of activated, terminally differentiated NK cells with augmented anti-tumor cytotoxicity.","method":"Bach2 conditional KO in NK cells, ATAC-seq, flow cytometry, tumor metastasis models","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with ATAC-seq and in vivo tumor metastasis functional readout","pmids":["36178457"],"is_preprint":false},{"year":2014,"finding":"BACH2 regulates apoptosis in pancreatic β-cells via JNK1 modulation: BACH2 inhibition exacerbates cytokine-induced β-cell apoptosis via the mitochondrial pathway by upregulating MKK7 and downregulating PTPN2, leading to increased JNK1 and BIM phosphorylation.","method":"BACH2 siRNA knockdown and overexpression in human and rodent β-cells, kinase activity assays, apoptosis assays","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2–3 — siRNA and overexpression with epistasis knockdowns of JNK1/BIM; single lab","pmids":["24608439"],"is_preprint":false},{"year":2017,"finding":"Bach2 directly represses the AP-1-driven induction of the interleukin-2 gene in CD4+ T cells by binding to multiple MARE-like sites on the IL-2 proximal promoter in a manner competitive with AP-1 factors.","method":"Luciferase reporter assay, ChIP, BACH2 overexpression and knockdown in primary and transformed CD4+ T cells","journal":"BMB reports","confidence":"Medium","confidence_rationale":"Tier 2–3 — ChIP and reporter assay with overexpression/knockdown; limited to single lab","pmids":["28855027"],"is_preprint":false},{"year":2018,"finding":"Bach2 promotes BCR-induced B-cell proliferation and survival by repressing cyclin-dependent kinase inhibitors (Cdkn1a, Cdkn2a, Cdkn2b) and maintaining expression of anti-apoptotic Bcl-xL. ChIP showed direct binding of Bach2 to CKI family gene loci.","method":"Bach2 KO mice, BrdU incorporation, ChIP, transcriptome analysis, Bcl-xL reconstitution","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating direct binding plus KO mouse with reconstitution experiment","pmids":["29540581"],"is_preprint":false},{"year":2024,"finding":"The relative strength of BLIMP1 versus BACH2 progressively increases in favor of BLIMP1 in antigen-responding B cells through primary responses, with epigenetic imprinting driven by IRF4 determining MBC fate upon recall. Skewing the BLIMP1-BACH2 balance in fate-predisposed MBC subsets can switch their fate preferences.","method":"Single-cell epigenomics, ATAC-seq, genetic manipulation of BLIMP1-BACH2 balance in MBC subsets, history-stamped GC B cell analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — single-cell multi-omic approaches with genetic fate-switching experiments","pmids":["38969872"],"is_preprint":false},{"year":2024,"finding":"BACH2 promotes immunomodulatory non-pathogenic TH17 programs and restrains proinflammatory TH1-like programs in TH17 cells. BACH2 establishes distinct chromatin landscapes in npTH17 versus pTH17 cells in vitro and in vivo, sharing accessible chromatin configurations with Treg cells in npTH17 cells.","method":"scATAC-seq, scRNA-seq, Bach2 KO in TH17 cells, in vitro and in vivo inflammatory disease models","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — single-cell chromatin and transcriptome profiling combined with genetic KO in multiple systems","pmids":["39009838"],"is_preprint":false}],"current_model":"BACH2 is a BTB-bZIP transcriptional repressor that, as a heterodimer with small Maf proteins or as a competing factor against AP-1/IRF4/BCL6 complexes at enhancers and promoters, suppresses effector differentiation programs in B cells (repressing Blimp-1/Prdm1 to enable CSR/SHM), CD4+ and CD8+ T cells (maintaining naive/regulatory states and preventing terminal differentiation), and innate lymphocytes (NK cells); its activity and subcellular localization are dynamically regulated by PI3K-Akt-mTORC1-mediated phosphorylation (at Ser-535 in mice), SENP3-mediated deSUMOylation (controlling nuclear retention), oxidative-stress-driven inhibition of CRM1-dependent nuclear export, and heme binding to an intrinsically disordered Cys-Pro-rich domain that inhibits DNA binding and promotes degradation."},"narrative":{"teleology":[{"year":1998,"claim":"Identification of BACH2 as a B-cell transcriptional repressor that heterodimerizes with small Maf proteins and binds MARE elements established the foundational molecular framework for understanding its repressive function.","evidence":"Co-IP, EMSA, and reporter assays in B-cell extracts identifying MafK heterodimerization and SMRT co-repressor binding","pmids":["9755173"],"confidence":"High","gaps":["Full repertoire of co-repressor complexes unknown","Genome-wide binding sites not mapped","Regulation of BACH2 activity not understood"]},{"year":2000,"claim":"Discovery that BACH2 undergoes CRM1-dependent nuclear export regulated by oxidative stress revealed the first mechanism controlling its subcellular localization and thus repressor activity.","evidence":"Leptomycin B treatment, CLS mutagenesis, and fluorescence microscopy showing oxidative stress blocks nuclear export","pmids":["10809773"],"confidence":"High","gaps":["Identity of reactive cysteines mediating redox sensitivity not defined","Physiological oxidative stimuli in immune cells not tested"]},{"year":2002,"claim":"Demonstration that oxidative stress drives BACH2 to PML nuclear body-associated foci and promotes apoptosis linked its redox-sensitive localization to a functional cellular outcome.","evidence":"Immunofluorescence co-localization with PML bodies and apoptosis assays in retroviral expression system","pmids":["11923289"],"confidence":"High","gaps":["Whether PML body association is required for apoptosis not resolved","Relevance to primary B cells not established"]},{"year":2004,"claim":"Genetic ablation of Bach2 proved it is essential for class switch recombination and somatic hypermutation, establishing BACH2 as a central regulator of B-cell diversification rather than merely a repressor of individual genes.","evidence":"Bach2 knockout mice with in vitro B-cell stimulation and immunoglobulin analysis","pmids":["15152264"],"confidence":"High","gaps":["Direct target genes mediating CSR/SHM requirement unknown","Mechanism linking BACH2 to AID regulation not defined"]},{"year":2004,"claim":"Discovery of BACH2 SUMOylation and its requirement for PML body recruitment, together with the BTB domain's role in focus formation and rapid dynamic turnover, defined how post-translational modification and oligomerization organize BACH2 into functional nuclear compartments.","evidence":"FRAP, sumoylation assays, BTB mutagenesis, and reporter assays","pmids":["15060166"],"confidence":"High","gaps":["SUMO site identity not mapped","Whether SUMOylation affects DNA-binding activity not tested"]},{"year":2006,"claim":"Identification of PRDM1/Blimp-1 as a direct BACH2 target gene provided the key mechanistic link explaining how BACH2 delays plasma cell differentiation and enables CSR.","evidence":"EMSA, ChIP at PRDM1 MARE, reporter assays, and shRNA knockdown in primary Bach2-deficient B cells","pmids":["17046816"],"confidence":"High","gaps":["Whether PRDM1 repression alone accounts for CSR rescue not tested","Genome-wide target repertoire not yet mapped"]},{"year":2006,"claim":"Discovery that BCR/ABL-driven PI3K/S6K signaling phosphorylates BACH2 at S521 to promote cytoplasmic retention established that oncogenic signaling inactivates BACH2 by controlling its localization.","evidence":"Site-directed mutagenesis, phosphorylation assays, subcellular fractionation in CML cells","pmids":["17018862"],"confidence":"High","gaps":["Whether this mechanism operates in normal B cells not shown","Identity of kinase directly phosphorylating S521 not fully resolved"]},{"year":2010,"claim":"Genetic epistasis showing that loss of Blimp-1 in Bach2-null B cells restores CSR proved that BACH2 acts upstream of Blimp-1 in the B-cell gene regulatory network, and that the CSR defect is due to premature Blimp-1 derepression.","evidence":"Bach2/Prdm1 double-knockout mice with mathematical modeling of the GRN","pmids":["20953163"],"confidence":"High","gaps":["Additional BACH2 targets contributing to GC B-cell program not fully defined","Whether time-delay model applies across all CSR isotypes not tested"]},{"year":2011,"claim":"Biochemical and structural characterization showed heme binds BACH2 to inhibit DNA binding and reduce protein stability, and the BTB domain crystal structure revealed a disulfide-linked homodimer, defining two key regulatory inputs and the structural basis for dimerization.","evidence":"In vitro heme-binding assays, pulse-chase stability assays, X-ray crystallography at 2.1 Å","pmids":["21444915","22194330"],"confidence":"High","gaps":["Physiological heme concentrations in B cells during differentiation not measured","How heme binding is coordinated with phosphorylation/SUMO signals unknown"]},{"year":2013,"claim":"A transformative set of studies extended BACH2's role beyond B cells: it was shown to broadly repress effector CD4+ T-cell programs (Th1/Th2/Th17), promote Foxp3+ Treg formation, maintain naive T-cell identity, activate p53 for pre-B cell negative selection, and cooperate with BCL6 genome-wide in GC B cells.","evidence":"Bach2 KO mice with ChIP-seq, genome-wide expression profiling, Treg transfer, pre-B cell leukemia models, and BCL6 co-occupancy analysis","pmids":["23728300","23754397","23852341","24277074"],"confidence":"High","gaps":["Whether BACH2 and BCL6 form a physical complex on chromatin not established by ChIP-seq alone","Mechanism by which BACH2 promotes Foxp3 transcription versus repressing competitors not resolved"]},{"year":2014,"claim":"BACH2 was shown to repress myeloid genes in common lymphoid progenitors to enforce B-cell lineage commitment and to promote erythroid over myeloid fate at the erythro-myeloid bifurcation, establishing BACH2 as a hematopoietic lineage decision factor beyond adaptive immunity.","evidence":"Bach2/Bach1 KO mice, single-cell CLP analysis, human CD34+ HSPC knockdown, ChIP at myeloid gene loci","pmids":["25344725","30250186"],"confidence":"High","gaps":["Relative contributions of BACH1 versus BACH2 at overlapping targets not delineated","Whether BACH2 directly represses myeloid TFs or acts through Cebpb alone not fully resolved"]},{"year":2015,"claim":"Identification of mTORC1 as the kinase directly phosphorylating BACH2 at Ser-535, with this single site being critical for cytoplasmic retention, unified the PI3K-Akt-mTOR signaling axis as the major pathway controlling BACH2 nuclear activity.","evidence":"Mass spectrometry phosphosite mapping, in vitro mTORC1 kinase assay, S535A mutagenesis in B cells","pmids":["26620562"],"confidence":"High","gaps":["Whether additional kinases phosphorylate other functionally relevant sites not fully explored","Phosphatase responsible for BACH2 dephosphorylation unknown"]},{"year":2016,"claim":"Multiple studies defined BACH2's mechanism in CD8+ T cells and Tregs: it occupies enhancers to compete with AP-1 factors at TCR-responsive elements, recruits HDAC3/NCoR co-repressor complexes to write repressive chromatin marks, and its haploinsufficiency causes human immunodeficiency (BRIDA).","evidence":"ChIP-seq/ATAC-seq in CD8+ T cells, mass spectrometry of BACH2 complex identifying HDAC3/NCoR/Rif1, and human genetics with protein stability assays","pmids":["27158840","26786103","28530713"],"confidence":"High","gaps":["Structural basis for AP-1 competition not resolved","BRIDA genotype-phenotype spectrum not fully characterized"]},{"year":2016,"claim":"Demonstration that BACH2-Batf heterodimers antagonize Batf-IRF4 complexes at AP-1 motifs in Th2 loci provided a specific molecular mechanism by which BACH2 competes for enhancer access with signal-dependent activating complexes.","evidence":"Co-IP, ChIP-seq, Bach2 KO mice with cytokine measurement","pmids":["27581382"],"confidence":"High","gaps":["Stoichiometry of BACH2-Batf versus Batf-IRF4 complexes not measured","Whether BACH2-Batf heterodimer has distinct DNA-binding specificity from BACH2-MafK not tested"]},{"year":2017,"claim":"The mTORC1/mTORC2 dual regulation of BACH2 (protein localization via mTORC1, mRNA expression via mTORC2-FoxO1) and the identification of BACH2-C/EBPβ mutual repression expanded the signaling network controlling BACH2 and its role in myeloid-lymphoid fate balance.","evidence":"mTOR inhibitor treatment with Bach2 KO epistasis; ChIP at Ccnd3 and Cebpb loci; LPS challenge experiments","pmids":["28993481","28273455"],"confidence":"High","gaps":["Whether mTORC2-FoxO1 regulation of Bach2 is direct or indirect not fully resolved","Kinetics of mTOR-BACH2 axis during in vivo immune responses not measured"]},{"year":2018,"claim":"Discovery that SENP3-mediated deSUMOylation of BACH2 prevents nuclear export and stabilizes Treg identity revealed a distinct post-translational mechanism (complementary to phosphorylation and heme binding) that controls BACH2 localization in a cell-type-specific manner.","evidence":"Treg-specific Senp3 conditional KO, SUMOylation assays, subcellular fractionation, tumor models","pmids":["30089837"],"confidence":"High","gaps":["Identity of SUMO acceptor lysines on BACH2 not mapped","Whether SENP3 regulation of BACH2 operates in B cells or CD8+ T cells not tested"]},{"year":2020,"claim":"Conditional KO studies with ChIP-seq/ATAC-seq in Tregs demonstrated that BACH2 maintains Treg quiescence by competing with AP-1 at enhancers and counteracting IRF4 to limit chromatin accessibility, with genetic epistasis proving BACH2 and IRF4 oppose each other at shared enhancers.","evidence":"Bach2 conditional KO and Bach2/IRF4 double conditional KO in Tregs with ATAC-seq and ChIP-seq","pmids":["32515782","31937752"],"confidence":"High","gaps":["How BACH2-IRF4 competition is resolved quantitatively during Treg activation not modeled","Whether BACH2 directly modifies IRF4 binding or acts indirectly via chromatin state not distinguished"]},{"year":2021,"claim":"Single-cell multi-omic profiling during chronic infection showed BACH2 establishes the stem-like CD8+ T-cell transcriptional and epigenetic program, suppressing terminal exhaustion and positioning BACH2 as a central determinant of T-cell longevity during persistent antigen exposure.","evidence":"scRNA-seq, scATAC-seq, BACH2 KO and overexpression in chronic viral infection models","pmids":["33574619"],"confidence":"High","gaps":["Downstream effectors of BACH2 in stem-like CD8+ T cells beyond known targets not identified","Whether BACH2 overexpression can rescue exhausted T cells not tested"]},{"year":2022,"claim":"Extension to innate lymphocytes showed BACH2 restricts NK cell maturation and terminal differentiation, demonstrating that BACH2's role as a brake on effector programs spans both adaptive and innate lymphoid lineages.","evidence":"Bach2 conditional KO in NK cells with ATAC-seq and tumor metastasis models","pmids":["36178457"],"confidence":"High","gaps":["Direct BACH2 target genes in NK cells not fully catalogued","Whether BACH2 interacts with the same co-repressor complexes in NK cells as in T/B cells unknown"]},{"year":2024,"claim":"Single-cell epigenomic studies of memory B-cell fate and TH17 plasticity showed that the BACH2-BLIMP1 balance is epigenetically imprinted by IRF4 during primary responses and that BACH2 establishes distinct chromatin landscapes favoring non-pathogenic TH17 programs, refining the model of BACH2 as an epigenetic gatekeeper.","evidence":"scATAC-seq and scRNA-seq in GC/MBC subsets and TH17 cells with genetic manipulation of BACH2-BLIMP1 balance","pmids":["38969872","39009838"],"confidence":"High","gaps":["Epigenetic marks directly written or maintained by BACH2-recruited complexes at specific loci not mapped genome-wide","How BACH2 levels are set in individual cells during stochastic fate decisions not resolved"]},{"year":null,"claim":"Key open questions include the full structural basis of BACH2-AP-1/IRF4 enhancer competition, the integration of multiple post-translational signals (phosphorylation, SUMOylation, heme, redox) in vivo, and whether BACH2's non-immune roles (e.g., pancreatic β-cells) employ the same co-repressor mechanisms.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length BACH2 structure available","In vivo quantitative dynamics of BACH2 post-translational modifications during immune activation not measured","Mechanism of BACH2 function in pancreatic islets not resolved relative to immune cell mechanism"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,5,10,22,34]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,5,12,14,22,26,34,36]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,35,39]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,4,21,30]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,6,21]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,12,14,22,25,34,36,39,44]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,5,14,22,26,36]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,21,27]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[22,36,43,44]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[18,25,28,31]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,13,40]}],"complexes":["BACH2-MafK heterodimer","BACH2-HDAC3-NCoR/SMRT co-repressor complex","BACH2-Batf heterodimer"],"partners":["MAFK","NCOR2","HDAC3","HDAC4","BCL6","BATF","RIF1","NCOR1"],"other_free_text":[]},"mechanistic_narrative":"BACH2 is a BTB-bZIP transcriptional repressor that functions as a master regulator of lymphoid and hematopoietic cell fate by suppressing effector differentiation programs across multiple immune lineages. It heterodimerizes with small Maf proteins (e.g., MafK) and binds MARE sequences at enhancers and promoters to repress key targets including PRDM1/Blimp-1, thereby creating a temporal window for class switch recombination and somatic hypermutation in B cells, maintaining naive and regulatory states in CD4+ and CD8+ T cells, restraining NK cell maturation, and promoting lymphoid over myeloid commitment in hematopoietic progenitors [PMID:9755173, PMID:15152264, PMID:23728300, PMID:22194330, PMID:36178457, PMID:25344725]. BACH2 achieves transcriptional repression by recruiting HDAC3-containing NCoR/SMRT co-repressor complexes and by competing with AP-1 (Jun/Batf) and IRF4 at shared enhancer elements, limiting chromatin accessibility for signal-dependent effector gene activation [PMID:26786103, PMID:27581382, PMID:27158840, PMID:31937752]. Its nuclear activity is dynamically regulated: PI3K-Akt-mTORC1-mediated phosphorylation at Ser-535 promotes cytoplasmic retention, SENP3-mediated deSUMOylation prevents nuclear export, oxidative stress inhibits CRM1-dependent export to enforce nuclear accumulation, and heme binding to an intrinsically disordered Cys-Pro-rich region inhibits DNA binding and accelerates degradation [PMID:26620562, PMID:30089837, PMID:10809773, PMID:25444856]. Heterozygous loss-of-function mutations in BACH2 cause BACH2-related immunodeficiency and autoimmunity (BRIDA) in humans [PMID:28530713]."},"prefetch_data":{"uniprot":{"accession":"Q9BYV9","full_name":"Transcription regulator protein BACH2","aliases":["BTB and CNC homolog 2"],"length_aa":841,"mass_kda":92.5,"function":"Transcriptional regulator that acts as a repressor or activator (By similarity). Binds to Maf recognition elements (MARE) (By similarity). Plays an important role in coordinating transcription activation and repression by MAFK (By similarity). Induces apoptosis in response to oxidative stress through repression of the antiapoptotic factor HMOX1 (PubMed:17018862). Positively regulates the nuclear import of actin (By similarity). Is a key regulator of adaptive immunity, crucial for the maintenance of regulatory T-cell function and B-cell maturation (PubMed:28530713)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9BYV9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BACH2","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BACH2","total_profiled":1310},"omim":[{"mim_id":"618394","title":"IMMUNODEFICIENCY 60 AND AUTOIMMUNITY; IMD60","url":"https://www.omim.org/entry/618394"},{"mim_id":"616977","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 43; MRD43","url":"https://www.omim.org/entry/616977"},{"mim_id":"605394","title":"BTB AND CNC HOMOLOGY 2; BACH2","url":"https://www.omim.org/entry/605394"},{"mim_id":"605165","title":"ZINC FINGER PROTEIN 278; ZNF278","url":"https://www.omim.org/entry/605165"},{"mim_id":"604874","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1; KLRG1","url":"https://www.omim.org/entry/604874"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":6.9},{"tissue":"lymphoid tissue","ntpm":16.3}],"url":"https://www.proteinatlas.org/search/BACH2"},"hgnc":{"alias_symbol":["BTBD25"],"prev_symbol":[]},"alphafold":{"accession":"Q9BYV9","domains":[{"cath_id":"3.30.710.10","chopping":"19-135","consensus_level":"high","plddt":92.833,"start":19,"end":135},{"cath_id":"1.10.880.10","chopping":"620-700","consensus_level":"high","plddt":92.922,"start":620,"end":700}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYV9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYV9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BYV9-F1-predicted_aligned_error_v6.png","plddt_mean":53.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BACH2","jax_strain_url":"https://www.jax.org/strain/search?query=BACH2"},"sequence":{"accession":"Q9BYV9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BYV9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BYV9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BYV9"}},"corpus_meta":[{"pmid":"23728300","id":"PMC_23728300","title":"BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23728300","citation_count":344,"is_preprint":false},{"pmid":"27158840","id":"PMC_27158840","title":"BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27158840","citation_count":259,"is_preprint":false},{"pmid":"15152264","id":"PMC_15152264","title":"The transcriptional programme of antibody class switching involves the repressor Bach2.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15152264","citation_count":244,"is_preprint":false},{"pmid":"20953163","id":"PMC_20953163","title":"Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20953163","citation_count":181,"is_preprint":false},{"pmid":"23850379","id":"PMC_23850379","title":"Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation.","date":"2013","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23850379","citation_count":178,"is_preprint":false},{"pmid":"33574619","id":"PMC_33574619","title":"BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33574619","citation_count":160,"is_preprint":false},{"pmid":"9755173","id":"PMC_9755173","title":"Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9755173","citation_count":157,"is_preprint":false},{"pmid":"23754397","id":"PMC_23754397","title":"Bach2 maintains T cells in a naive state by suppressing effector memory-related genes.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23754397","citation_count":139,"is_preprint":false},{"pmid":"17046816","id":"PMC_17046816","title":"Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17046816","citation_count":138,"is_preprint":false},{"pmid":"28530713","id":"PMC_28530713","title":"BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency.","date":"2017","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28530713","citation_count":122,"is_preprint":false},{"pmid":"25344725","id":"PMC_25344725","title":"The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.","date":"2014","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25344725","citation_count":113,"is_preprint":false},{"pmid":"30089837","id":"PMC_30089837","title":"SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30089837","citation_count":113,"is_preprint":false},{"pmid":"17262715","id":"PMC_17262715","title":"Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.","date":"2007","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17262715","citation_count":110,"is_preprint":false},{"pmid":"23852341","id":"PMC_23852341","title":"BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.","date":"2013","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23852341","citation_count":101,"is_preprint":false},{"pmid":"24127487","id":"PMC_24127487","title":"Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24127487","citation_count":100,"is_preprint":false},{"pmid":"21444915","id":"PMC_21444915","title":"Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21444915","citation_count":98,"is_preprint":false},{"pmid":"18256039","id":"PMC_18256039","title":"Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6.","date":"2008","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18256039","citation_count":97,"is_preprint":false},{"pmid":"24367030","id":"PMC_24367030","title":"Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24367030","citation_count":96,"is_preprint":false},{"pmid":"10809773","id":"PMC_10809773","title":"Oxidative stress abolishes leptomycin B-sensitive nuclear export of transcription repressor Bach2 that counteracts activation of Maf recognition element.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10809773","citation_count":95,"is_preprint":false},{"pmid":"28887441","id":"PMC_28887441","title":"HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28887441","citation_count":93,"is_preprint":false},{"pmid":"29129929","id":"PMC_29129929","title":"IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29129929","citation_count":92,"is_preprint":false},{"pmid":"24608439","id":"PMC_24608439","title":"BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic β-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24608439","citation_count":92,"is_preprint":false},{"pmid":"24277074","id":"PMC_24277074","title":"Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24277074","citation_count":84,"is_preprint":false},{"pmid":"24694524","id":"PMC_24694524","title":"The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24694524","citation_count":83,"is_preprint":false},{"pmid":"11923289","id":"PMC_11923289","title":"Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11923289","citation_count":82,"is_preprint":false},{"pmid":"27581382","id":"PMC_27581382","title":"Bach2-Batf interactions control Th2-type immune response by regulating the IL-4 amplification loop.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27581382","citation_count":79,"is_preprint":false},{"pmid":"31937752","id":"PMC_31937752","title":"Attenuation of TCR-induced transcription by Bach2 controls regulatory T cell differentiation and homeostasis.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31937752","citation_count":77,"is_preprint":false},{"pmid":"25678371","id":"PMC_25678371","title":"miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2.","date":"2015","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25678371","citation_count":73,"is_preprint":false},{"pmid":"25123280","id":"PMC_25123280","title":"Orchestration of plasma cell differentiation by Bach2 and its gene regulatory network.","date":"2014","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/25123280","citation_count":70,"is_preprint":false},{"pmid":"26786103","id":"PMC_26786103","title":"Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26786103","citation_count":65,"is_preprint":false},{"pmid":"31819031","id":"PMC_31819031","title":"Bach2 deficiency leads autoreactive B cells to produce IgG autoantibodies and induce lupus through a T cell-dependent extrafollicular pathway.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31819031","citation_count":63,"is_preprint":false},{"pmid":"10949928","id":"PMC_10949928","title":"Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10949928","citation_count":59,"is_preprint":false},{"pmid":"32515782","id":"PMC_32515782","title":"BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32515782","citation_count":58,"is_preprint":false},{"pmid":"27496973","id":"PMC_27496973","title":"T Cell Fates Zipped Up: How the Bach2 Basic Leucine Zipper Transcriptional Repressor Directs T Cell Differentiation and Function.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27496973","citation_count":57,"is_preprint":false},{"pmid":"14982850","id":"PMC_14982850","title":"Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression.","date":"2004","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/14982850","citation_count":55,"is_preprint":false},{"pmid":"34907913","id":"PMC_34907913","title":"BACH2 inhibition reverses β cell failure in type 2 diabetes models.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34907913","citation_count":54,"is_preprint":false},{"pmid":"26731475","id":"PMC_26731475","title":"The transcription factor BACH2 promotes tumor immunosuppression.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26731475","citation_count":54,"is_preprint":false},{"pmid":"17018862","id":"PMC_17018862","title":"Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17018862","citation_count":54,"is_preprint":false},{"pmid":"24022229","id":"PMC_24022229","title":"Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data.","date":"2013","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/24022229","citation_count":49,"is_preprint":false},{"pmid":"28273455","id":"PMC_28273455","title":"A Bach2-Cebp Gene Regulatory Network for the Commitment of Multipotent Hematopoietic Progenitors.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28273455","citation_count":48,"is_preprint":false},{"pmid":"22899287","id":"PMC_22899287","title":"Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics.","date":"2012","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/22899287","citation_count":48,"is_preprint":false},{"pmid":"30833348","id":"PMC_30833348","title":"Bach2 Controls T Follicular Helper Cells by Direct Repression of Bcl-6.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30833348","citation_count":48,"is_preprint":false},{"pmid":"12829606","id":"PMC_12829606","title":"B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12829606","citation_count":45,"is_preprint":false},{"pmid":"32082072","id":"PMC_32082072","title":"The Critical Role of Bach2 in Shaping the Balance between CD4+ T Cell Subsets in Immune-Mediated Diseases.","date":"2019","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/32082072","citation_count":44,"is_preprint":false},{"pmid":"15060166","id":"PMC_15060166","title":"Repression of PML nuclear body-associated transcription by oxidative stress-activated Bach2.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15060166","citation_count":44,"is_preprint":false},{"pmid":"31552021","id":"PMC_31552021","title":"Bach2 Deficiency Leads to Spontaneous Expansion of IL-4-Producing T Follicular Helper Cells and Autoimmunity.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31552021","citation_count":39,"is_preprint":false},{"pmid":"31918262","id":"PMC_31918262","title":"Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31918262","citation_count":38,"is_preprint":false},{"pmid":"25444856","id":"PMC_25444856","title":"Heme binds to an intrinsically disordered region of Bach2 and alters its conformation.","date":"2014","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/25444856","citation_count":36,"is_preprint":false},{"pmid":"26620562","id":"PMC_26620562","title":"The Transcription Factor Bach2 Is Phosphorylated at Multiple Sites in Murine B Cells but a Single Site Prevents Its Nuclear Localization.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26620562","citation_count":36,"is_preprint":false},{"pmid":"27807919","id":"PMC_27807919","title":"Extended exome sequencing identifies BACH2 as a novel major risk locus for Addison's disease.","date":"2016","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27807919","citation_count":36,"is_preprint":false},{"pmid":"11746976","id":"PMC_11746976","title":"Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene.","date":"2001","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11746976","citation_count":35,"is_preprint":false},{"pmid":"23936317","id":"PMC_23936317","title":"Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23936317","citation_count":34,"is_preprint":false},{"pmid":"30250186","id":"PMC_30250186","title":"Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia.","date":"2018","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30250186","citation_count":33,"is_preprint":false},{"pmid":"26522720","id":"PMC_26522720","title":"The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26522720","citation_count":33,"is_preprint":false},{"pmid":"28030830","id":"PMC_28030830","title":"Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28030830","citation_count":32,"is_preprint":false},{"pmid":"21319257","id":"PMC_21319257","title":"Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.","date":"2011","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21319257","citation_count":32,"is_preprint":false},{"pmid":"28993481","id":"PMC_28993481","title":"The mTOR-Bach2 Cascade Controls Cell Cycle and Class Switch Recombination during B Cell Differentiation.","date":"2017","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28993481","citation_count":32,"is_preprint":false},{"pmid":"30971440","id":"PMC_30971440","title":"Bach2 Negatively Regulates T Follicular Helper Cell Differentiation and Is Critical for CD4+ T Cell Memory.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30971440","citation_count":32,"is_preprint":false},{"pmid":"24332591","id":"PMC_24332591","title":"BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint.","date":"2013","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24332591","citation_count":31,"is_preprint":false},{"pmid":"26444573","id":"PMC_26444573","title":"Transcriptome Analysis of CD4+ T Cells in Coeliac Disease Reveals Imprint of BACH2 and IFNγ Regulation.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26444573","citation_count":31,"is_preprint":false},{"pmid":"29991969","id":"PMC_29991969","title":"Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease.","date":"2018","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/29991969","citation_count":30,"is_preprint":false},{"pmid":"28487475","id":"PMC_28487475","title":"MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression.","date":"2017","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/28487475","citation_count":30,"is_preprint":false},{"pmid":"35313725","id":"PMC_35313725","title":"Bach2: A Key Regulator in Th2-Related Immune Cells and Th2 Immune Response.","date":"2022","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/35313725","citation_count":29,"is_preprint":false},{"pmid":"29540581","id":"PMC_29540581","title":"Bach2 Promotes B Cell Receptor-Induced Proliferation of B Lymphocytes and Represses Cyclin-Dependent Kinase Inhibitors.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29540581","citation_count":28,"is_preprint":false},{"pmid":"33979619","id":"PMC_33979619","title":"Bach2 attenuates IL-2R signaling to control Treg homeostasis and Tfr development.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33979619","citation_count":27,"is_preprint":false},{"pmid":"12204112","id":"PMC_12204112","title":"Expression of the oxidative stress-regulated transcription factor bach2 in differentiating neuronal cells.","date":"2002","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12204112","citation_count":27,"is_preprint":false},{"pmid":"22858985","id":"PMC_22858985","title":"Transcriptional suppression of BACH2 by the Bcr-Abl oncoprotein is mediated by PAX5.","date":"2012","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/22858985","citation_count":25,"is_preprint":false},{"pmid":"36178457","id":"PMC_36178457","title":"BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36178457","citation_count":24,"is_preprint":false},{"pmid":"21296099","id":"PMC_21296099","title":"Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.","date":"2011","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21296099","citation_count":24,"is_preprint":false},{"pmid":"38969872","id":"PMC_38969872","title":"Epigenetic recording of stimulation history reveals BLIMP1-BACH2 balance in determining memory B cell fate upon recall challenge.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38969872","citation_count":23,"is_preprint":false},{"pmid":"24075570","id":"PMC_24075570","title":"BACH2: a marker of DNA damage and ageing.","date":"2013","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/24075570","citation_count":23,"is_preprint":false},{"pmid":"29511557","id":"PMC_29511557","title":"Bach2 repression mediates Th17 cell induced inflammation and associates with clinical features of advanced disease in chronic pancreatitis.","date":"2017","source":"United European gastroenterology journal","url":"https://pubmed.ncbi.nlm.nih.gov/29511557","citation_count":23,"is_preprint":false},{"pmid":"19159451","id":"PMC_19159451","title":"Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas.","date":"2009","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19159451","citation_count":23,"is_preprint":false},{"pmid":"24346624","id":"PMC_24346624","title":"Identification of BACH2 as a susceptibility gene for Graves' disease in the Chinese Han population based on a three-stage genome-wide association study.","date":"2013","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24346624","citation_count":22,"is_preprint":false},{"pmid":"33882335","id":"PMC_33882335","title":"Bach2 regulates autophagy to modulate UVA-induced photoaging in skin fibroblasts.","date":"2021","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33882335","citation_count":22,"is_preprint":false},{"pmid":"29230020","id":"PMC_29230020","title":"SNP co-association and network analyses identify E2F3, KDM5A and BACH2 as key regulators of the bovine milk fatty acid profile.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29230020","citation_count":21,"is_preprint":false},{"pmid":"27387751","id":"PMC_27387751","title":"The double knockout of Bach1 and Bach2 in mice reveals shared compensatory mechanisms in regulating alveolar macrophage function and lung surfactant homeostasis.","date":"2016","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27387751","citation_count":21,"is_preprint":false},{"pmid":"21412927","id":"PMC_21412927","title":"A BACH2-BCL2L1 fusion gene resulting from a t(6;20)(q15;q11.2) chromosomal translocation in the lymphoma cell line BLUE-1.","date":"2011","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21412927","citation_count":21,"is_preprint":false},{"pmid":"39009838","id":"PMC_39009838","title":"BACH2 regulates diversification of regulatory and proinflammatory chromatin states in TH17 cells.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39009838","citation_count":20,"is_preprint":false},{"pmid":"17991429","id":"PMC_17991429","title":"The role of Bach2 in nucleic acid-triggered antiviral innate immune responses.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17991429","citation_count":19,"is_preprint":false},{"pmid":"28592433","id":"PMC_28592433","title":"Bifurcated BACH2 control coordinates mantle cell lymphoma survival and dispersal during hypoxia.","date":"2017","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/28592433","citation_count":18,"is_preprint":false},{"pmid":"33966174","id":"PMC_33966174","title":"Polymorphism in BACH2 gene is a marker of polyglandular autoimmunity.","date":"2021","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/33966174","citation_count":17,"is_preprint":false},{"pmid":"36190189","id":"PMC_36190189","title":"The transcription factor Bach2 negatively regulates murine natural killer cell maturation and function.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36190189","citation_count":17,"is_preprint":false},{"pmid":"35793628","id":"PMC_35793628","title":"Diverging regulation of Bach2 protein and RNA expression determine cell fate in early B cell response.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35793628","citation_count":17,"is_preprint":false},{"pmid":"27206783","id":"PMC_27206783","title":"Charge-state-distribution analysis of Bach2 intrinsically disordered heme binding region.","date":"2016","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27206783","citation_count":16,"is_preprint":false},{"pmid":"34389622","id":"PMC_34389622","title":"Continuous Culture of Mouse Primary B Lymphocytes by Forced Expression of Bach2.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/34389622","citation_count":16,"is_preprint":false},{"pmid":"27680876","id":"PMC_27680876","title":"A Variant in the BACH2 Gene Is Associated With Susceptibility to Autoimmune Addison's Disease in Humans.","date":"2016","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27680876","citation_count":16,"is_preprint":false},{"pmid":"33249782","id":"PMC_33249782","title":"Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.","date":"2020","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/33249782","citation_count":15,"is_preprint":false},{"pmid":"17383980","id":"PMC_17383980","title":"Co-repressor SMRT and class II histone deacetylases promote Bach2 nuclear retention and formation of nuclear foci that are responsible for local transcriptional repression.","date":"2007","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17383980","citation_count":15,"is_preprint":false},{"pmid":"32892482","id":"PMC_32892482","title":"Interaction of BACH2 with FUS promotes malignant progression of glioma cells via the TSLNC8-miR-10b-5p-WWC3 pathway.","date":"2020","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32892482","citation_count":15,"is_preprint":false},{"pmid":"28855027","id":"PMC_28855027","title":"Bach2 represses the AP-1-driven induction of interleukin-2 gene transcription in CD4＋ T cells.","date":"2017","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/28855027","citation_count":15,"is_preprint":false},{"pmid":"22194330","id":"PMC_22194330","title":"The structure of the Bach2 POZ-domain dimer reveals an intersubunit disulfide bond.","date":"2011","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/22194330","citation_count":15,"is_preprint":false},{"pmid":"29529253","id":"PMC_29529253","title":"The critical role of Bach2 in regulating type 2 chronic airway inflammation.","date":"2018","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29529253","citation_count":14,"is_preprint":false},{"pmid":"30654767","id":"PMC_30654767","title":"Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.","date":"2019","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30654767","citation_count":14,"is_preprint":false},{"pmid":"32509061","id":"PMC_32509061","title":"miR-16-5p and miR-145-5p trigger apoptosis in human gingival epithelial cells by down-regulating BACH2.","date":"2020","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32509061","citation_count":14,"is_preprint":false},{"pmid":"28301039","id":"PMC_28301039","title":"Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells.","date":"2017","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28301039","citation_count":13,"is_preprint":false},{"pmid":"35264460","id":"PMC_35264460","title":"CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory-like Cells.","date":"2022","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/35264460","citation_count":13,"is_preprint":false},{"pmid":"18769450","id":"PMC_18769450","title":"Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4+ T cells.","date":"2008","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/18769450","citation_count":13,"is_preprint":false},{"pmid":"28123644","id":"PMC_28123644","title":"microRNA-142 is upregulated by tumor necrosis factor-alpha and triggers apoptosis in human gingival epithelial cells by repressing BACH2 expression.","date":"2017","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/28123644","citation_count":13,"is_preprint":false},{"pmid":"16631738","id":"PMC_16631738","title":"Bach2 is involved in neuronal differentiation of N1E-115 neuroblastoma cells.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16631738","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47879,"output_tokens":9999,"usd":0.146811},"stage2":{"model":"claude-opus-4-6","input_tokens":14005,"output_tokens":5127,"usd":0.2973},"total_usd":0.444111,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"BACH2 was identified as a B-cell-specific transcription factor that forms heterodimers with small Maf proteins (e.g., MafK) and binds to Maf recognition elements (MAREs) in the IgH 3' enhancer, acting as a negative regulator. BACH2 also binds the co-repressor SMRT.\",\n      \"method\": \"Co-immunoprecipitation, EMSA, B-cell extract binding assays, reporter assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (EMSA, pulldown, reporter assays) in foundational paper; widely replicated\",\n      \"pmids\": [\"9755173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BACH2 is regulated by oxidative stress-sensitive conditional nuclear export via a C-terminal cytoplasmic localization signal (CLS) that directs leptomycin B-sensitive (CRM1/exportin-1-dependent) nuclear export. Oxidative stressors abrogate this CLS activity, causing nuclear accumulation of BACH2 and repression of MARE-dependent transcription.\",\n      \"method\": \"Mutagenesis, leptomycin B treatment, fluorescence microscopy, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis of CLS combined with pharmacological inhibition and reporter assays; replicated by subsequent studies\",\n      \"pmids\": [\"10809773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Upon oxidative stress, BACH2 forms nuclear foci associated with PML nuclear bodies and promotes apoptosis. BACH2 acts as a generic repressor of TRE-, MARE-, and ARE-driven transcription, and its nuclear accumulation upon oxidative stress is required but not sufficient for apoptosis induction.\",\n      \"method\": \"Retroviral bicistronic reporter, fluorescence microscopy, apoptosis assays, immunofluorescence co-localization with PML bodies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single lab but multiple orthogonal methods; specificity demonstrated by comparison with Bach1\",\n      \"pmids\": [\"11923289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BACH2 is required for class switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin genes in activated B cells. Genetic ablation of Bach2 in mice shows it is not required for plasma cell differentiation per se but is essential for the CSR process.\",\n      \"method\": \"Bach2 knockout mice, in vitro B-cell stimulation, immunoglobulin analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple immunological readouts; highly cited foundational paper\",\n      \"pmids\": [\"15152264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Upon oxidative stress, BACH2 is sumoylated, which is required for its recruitment around PML nuclear bodies. BACH2 selectively represses transcription associated with PML bodies; FRAP experiments revealed rapid turnover of BACH2 in nuclear foci, and the BTB domain is essential for focus formation.\",\n      \"method\": \"Fluorescence recovery after photobleaching (FRAP), mutagenesis, sumoylation assays, reporter gene assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — FRAP, mutagenesis, and functional reporter assays in single rigorous paper\",\n      \"pmids\": [\"15060166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BACH2 directly represses expression of Blimp-1 (encoded by Prdm1) in B cells by binding as a heterodimer with MafK to the MARE upstream of the Prdm1 promoter and in intron 5. Loss of BACH2 leads to more rapid and robust Blimp-1 induction and plasma cell differentiation.\",\n      \"method\": \"EMSA, ChIP, reporter assays, shRNA knockdown, primary Bach2-deficient B cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including EMSA, ChIP, and functional assays; replicated across labs\",\n      \"pmids\": [\"17046816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BCR/ABL signaling phosphorylates BACH2 at S521 via the PI3K/S6 kinase pathway, which promotes cytoplasmic retention of BACH2 and prevents nuclear accumulation. Mutation of S521 to alanine leads to nuclear accumulation and greater growth inhibition of CML cells.\",\n      \"method\": \"Mutagenesis, phosphorylation assays, subcellular fractionation, cell growth assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — site-directed mutagenesis combined with functional localization studies\",\n      \"pmids\": [\"17018862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SMRT co-repressor mediates HDAC4 binding to BACH2; HDAC4 facilitates retention of BACH2 in nuclear foci. Co-expression of SMRT and HDAC4 enhances BACH2 nuclear focus formation and local transcriptional repression at MARE-containing reporter genes.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy, scratch transcription labeling, reporter assays\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP and functional assays in single lab; mechanistic detail limited to one paper\",\n      \"pmids\": [\"17383980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BACH2 interacts with BCL6 in B cells in a BTB-domain-independent manner. Both BACH2 and BCL6 bind to separate regulatory elements (MARE and BCL6-binding element, respectively) of the Prdm1 gene and cooperate to repress its expression; co-expression results in greater repression.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, reporter assays\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP and ChIP in single lab with functional reporter validation\",\n      \"pmids\": [\"18256039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BACH2 represses Blimp-1 in B cells to create a time delay in plasma cell differentiation, allowing a window for class switch recombination. Genetic loss of Blimp-1 in Bach2-/- B cells restores CSR, establishing that Bach2 acts upstream of Blimp-1 in the B-cell gene regulatory network.\",\n      \"method\": \"Double-knockout mouse genetics, mathematical modeling of GRN, in vitro B-cell stimulation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via double-KO mice; replicated and mechanistically validated\",\n      \"pmids\": [\"20953163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Heme binds to BACH2 and inhibits its DNA-binding activity in vitro; heme also reduces BACH2 half-life in B cells. Heme treatment of B cells enhances Blimp-1 transcription and skews plasma cell differentiation toward IgM. Heme oxygenase-1 is repressed by both BACH2 and BACH1 in B cells.\",\n      \"method\": \"In vitro DNA-binding assay, pulse-chase protein stability assay, B-cell culture with heme treatment, reporter assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro biochemical assay plus cellular functional validation; replicated in structural study\",\n      \"pmids\": [\"21444915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structure of the human BACH2 POZ/BTB domain dimer was solved at 2.1 Å resolution. The structure reveals an intersubunit disulfide bond present both in bacterially expressed protein and in eukaryotic cells. The BTB domain mediates dimerization and recruits co-repressors including class II HDACs.\",\n      \"method\": \"X-ray crystallography, biochemical validation in solution and in transfected eukaryotic cells\",\n      \"journal\": \"Acta crystallographica. Section D, Biological crystallography\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure at 2.1 Å with biochemical validation\",\n      \"pmids\": [\"22194330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BACH2 broadly represses effector CD4+ T-cell differentiation programs (Th1, Th2, Th17) while being required for efficient Foxp3+ Treg cell formation. In Bach2-deficient mice, Treg polarization results in inappropriate diversion to effector lineages, and lethal inflammation is suppressed in a Treg-dependent manner. Genome-wide BACH2 occupancy showed enrichment at enhancers of effector differentiation genes.\",\n      \"method\": \"Bach2 knockout mice, ChIP-seq, genome-wide expression profiling, Treg transfer experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice with ChIP-seq and multiple cellular phenotypic readouts; highly cited and widely replicated\",\n      \"pmids\": [\"23728300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BACH2 activates p53 to mediate negative selection of pre-B cells that fail productive VH-DJH rearrangement. Pre-BCR signaling ends BACH2-mediated negative selection via BCL6-mediated repression of p53. BACH2 competes with BCL6 for promoter binding and reverses BCL6-mediated repression of p53 and cell cycle checkpoint genes.\",\n      \"method\": \"ChIP-seq, gene expression analysis, Bach2 knockout pre-B cells, leukemia transplant experiments\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus genetic epistasis and functional in vivo assays\",\n      \"pmids\": [\"23852341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BACH2 maintains naive T cells by suppressing effector-memory-related genes including CCR4, ST-2, and Blimp-1. ChIP-seq identified direct BACH2 target genes (S100 calcium binding protein a, Heme oxygenase-1, prolyl hydroxylase 3). Forced expression of BACH2 restored expression of these genes.\",\n      \"method\": \"ChIP-seq, Bach2-deficient mouse T-cell analysis, forced expression experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq with genetic KO and forced expression rescue\",\n      \"pmids\": [\"23754397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Antigen-experienced IgG1 memory B cells have repressed Bach2 expression compared to non-experienced IgG1 B cells, and this Bach2 repression contributes to predisposition toward plasma cell differentiation upon rechallenge.\",\n      \"method\": \"Engineered mice with non-experienced IgG1 B cells, gene expression analysis, in vivo rechallenge experiments\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic mouse model with mechanistic link between Bach2 repression and cell fate; single lab\",\n      \"pmids\": [\"23850379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Bach2 cooperates with BCL6 in germinal center B cells to repress the plasma cell program. BCL6 and BACH2 bind overlapping sets of target genes (~30% peak overlap), including PRDM1 cis-regulatory sequences. BACH2 binds predominantly with heterodimer partner MAFK. BCL6 also modulates BACH2 protein stability, and their levels are positively correlated in GC B cells.\",\n      \"method\": \"ChIP-seq, double-heterozygous knockout mice, protein stability assays, B-cell gene expression profiling\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq combined with double-heterozygous genetic model and biochemical stability assays\",\n      \"pmids\": [\"24277074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BACH2 promotes Foxp3 expression in a TCR/TGF-β-induced Treg differentiation assay and represses the competing Gata3-driven Th2 effector program. Bach2-deficient Treg cells show reduced Bcl-2 and Mcl-1 levels and elevated Bim/Bcl-2 ratio, contributing to reduced survival.\",\n      \"method\": \"Bach2 KO mouse, in vitro Treg induction assay, flow cytometry, gene expression analysis\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mice with mechanistic in vitro rescue experiments; single lab\",\n      \"pmids\": [\"24367030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BACH2 represses myeloid genes in B-cell progenitors (common lymphoid progenitors) to promote B-cell lineage commitment. Bach2 and Bach1 bind presumptive regulatory regions of myeloid genes. Bach2-high CLPs are resistant to myeloid differentiation even under myeloid culture conditions.\",\n      \"method\": \"Bach2/Bach1 KO mice, single-cell analysis of CLPs, ChIP, overexpression in pre-pro-B cells lacking EBF1\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice, single-cell analysis, and ChIP with functional differentiation assays\",\n      \"pmids\": [\"25344725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Menin binds to the Bach2 locus and controls its expression through maintenance of histone acetylation. T cell-specific Menin deficiency results in decreased Bach2 expression and premature CD4+ T cell senescence; this Menin-Bach2 axis regulates cytokine homeostasis.\",\n      \"method\": \"T cell-specific Menin conditional KO mice, ChIP at Bach2 locus, histone acetylation analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating Menin binding at Bach2 locus with conditional KO phenotypic validation\",\n      \"pmids\": [\"24694524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Heme binds to an intrinsically disordered region (residues 331–520) of BACH2 containing Cys-Pro motifs. Heme binding is in 5- and 6-coordinated modes, induces conformational changes (revealed by CD, SAXS, DLS), and alters protein interactions mediated by this region. The CP-motif mutant lacks 5-coordinated heme binding.\",\n      \"method\": \"Spectroscopic analysis (UV-Vis, CD), dynamic light scattering, small-angle X-ray scattering, chemical modification, GAL4-based luciferase assay\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods defining heme-binding domain and conformational changes\",\n      \"pmids\": [\"25444856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bach2 is phosphorylated at multiple sites in B cells via the PI3K-Akt-mTOR pathway. The mTOR complex 1 (mTORC1) phosphorylates Bach2 in vitro. A single phosphorylation site, Ser-535 (murine), is critical: the Ser-535 mutation abolishes cytoplasmic accumulation and promotes nuclear localization, enhancing Bach2 repressor activity.\",\n      \"method\": \"Mass spectrometry phosphosite identification, kinase inhibitors, mTORC1 in vitro phosphorylation assay, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay, mass spectrometry, and mutagenesis identifying critical phosphorylation site\",\n      \"pmids\": [\"26620562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BACH2 is recruited to enhancers in naive CD8+ T cells, where it limits expression of TCR-driven effector genes by attenuating AP-1 site availability to Jun family signal-dependent transcription factors. Upon effector differentiation, reduced BACH2 expression and its phosphorylation enable unrestrained TCR-driven effector programs.\",\n      \"method\": \"ChIP-seq, ATAC-seq, BACH2 KO mouse, viral infection models\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq and ATAC-seq combined with genetic KO; highly cited\",\n      \"pmids\": [\"27158840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bach2 associates with Batf and together the Bach2-Batf complex binds to regulatory regions of Th2 cytokine gene loci. This complex antagonizes the Batf-Irf4 complex at AP-1 motifs, suppressing Th2 cytokine production. Bach2 also regulates Batf/Batf3 expression by inhibiting IL-4 production and directly repressing Batf/Batf3 gene loci.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, Bach2 KO mouse, cytokine measurement assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, ChIP-seq, and genetic KO with functional cytokine readouts\",\n      \"pmids\": [\"27581382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BACH2 haploinsufficiency causes a syndrome of immunodeficiency and autoimmunity (BRIDA). BACH2 mutations disrupt protein stability by interfering with homodimerization or causing aggregation. BACH2 is associated with a super-enhancer architecture, and SE-associated gene haploinsufficiency is enriched among Mendelian immunodeficiency diseases.\",\n      \"method\": \"Human genetics, patient cell studies, protein stability assays, homodimerization assays, SE chromatin analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional protein studies combined with human disease genetics; orthologous mouse findings\",\n      \"pmids\": [\"28530713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BACH2 promotes tumor immunosuppression through Treg-mediated inhibition of intratumoral CD8+ T cells and IFN-γ. In Bach2-deficient mice, tumor growth is markedly impaired, with high frequencies of rapidly proliferating effector T cells and reduced intratumoral Foxp3+ Tregs.\",\n      \"method\": \"Bach2 KO mouse tumor implantation models, adoptive transfer experiments, intratumoral lymphocyte analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO experiments with mechanistic T cell transfer studies\",\n      \"pmids\": [\"26731475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The epigenetic regulation of Prdm1 in B cells involves BACH2 interacting with HDAC3-containing co-repressor complexes (including NCoR1, NCoR2, Tbl1x, and Rif1) to write histone deacetylation marks at the Prdm1 intron 5 MARE. ChIP confirmed binding of HDAC3 and Rif1 to the Prdm1 locus; knockdown of HDAC3 or NCoR1 increased Prdm1 expression.\",\n      \"method\": \"Purification of Bach2 complex by mass spectrometry, ChIP, RNA interference knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — complex purification by MS, ChIP, and functional RNAi in same study\",\n      \"pmids\": [\"26786103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"mTOR complex 1 (mTORC1) inhibits nuclear accumulation and stability of Bach2, while mTOR complex 2 (mTORC2) inhibits FoxO1 to reduce Bach2 mRNA expression. Bach2 directly regulates Ccnd3 (cyclin D3) expression. The mTOR-Bach2 cascade controls proper cell cycle arrest in B cells, and mTOR inhibition enhances CSR in a Bach2-dependent manner.\",\n      \"method\": \"mTOR inhibitor treatment, Bach2 KO mice, ChIP, expression profiling, cell cycle analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP identifying direct target plus pharmacological-genetic epistasis; multiple orthogonal approaches\",\n      \"pmids\": [\"28993481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Bach2 and C/EBPβ form a mutual repression gene regulatory network in multipotent hematopoietic progenitors. Bach2 represses Cebpb and Csf1r; C/EBPβ represses Bach2 and activates Csf1r. Both factors bind overlapping regulatory regions at myeloid target genes. LPS reduces Bach2 expression, enhancing myeloid differentiation.\",\n      \"method\": \"ChIP, gene expression profiling, KO mouse models, LPS stimulation experiments\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with genetic KO models and LPS functional challenge\",\n      \"pmids\": [\"28273455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IL-2 drives BACH2 repression via ERK/ELK1 signaling to direct plasma cell lineage commitment in human naive B cells. Enforced BACH2 repression unlocks the plasma cell transcriptional program. An active regulatory region within the BACH2 super-enhancer is under ELK1 control.\",\n      \"method\": \"RNA-seq, ChIP-seq, ERK/ELK1 inhibitors, B-cell differentiation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — RNA-seq and ChIP-seq combined with functional pathway inhibition; human cells\",\n      \"pmids\": [\"29129929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SENP3-mediated deSUMOylation of BACH2 prevents its nuclear export, thereby repressing effector T-cell differentiation genes and stabilizing Treg cell-specific gene signatures. Treg-specific deletion of Senp3 results in T-cell activation and autoimmune symptoms. ROS accumulation promotes SENP3 accumulation in Treg cells involved in tumor immunosuppression.\",\n      \"method\": \"Treg-specific Senp3 conditional KO mice, SUMOylation assays, subcellular fractionation, ChIP, tumor immunosuppression models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO combined with biochemical SUMOylation assays and localization studies\",\n      \"pmids\": [\"30089837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bach2 and Bach1 promote erythroid commitment by repressing the myeloid transcription factor gene Cebpb and its targets at the erythro-myeloid bifurcation step. Bach TFs bind to regulatory regions co-occupied by C/EBPβ. Knockdown of BACH1 or BACH2 in human CD34+ HSPCs impairs erythroid differentiation in vitro.\",\n      \"method\": \"ChIP, Bach2/Bach1 KO and overexpression in HSPCs, human CD34+ siRNA knockdown, erythroid differentiation assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus genetic KO/OE and human cell knockdown with differentiation phenotype\",\n      \"pmids\": [\"30250186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bach2 directly suppresses Bcl-6 transcription in Tfh cells by binding to the Bcl-6 promoter and replacing an activating Batf-Irf4 complex, thereby controlling the Tfh cell transcriptional network. This is mechanistically distinct from GC B cells, where Bach2 and Bcl-6 are co-expressed.\",\n      \"method\": \"Ectopic overexpression in murine Tfh cells, reporter assays, ChIP at Bcl-6 promoter\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — ChIP and functional reporter in overexpression model; mechanistic detail from single lab\",\n      \"pmids\": [\"30833348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bach2 directly suppresses CXCR5 and c-Maf expression in CD4+ T cells by binding to a regulatory element in the CXCR5 locus. Bach2 deficiency results in preferential Tfh cell differentiation but ultimately collapsed CD4+ T cell memory.\",\n      \"method\": \"Bach2 KO mouse, identification of novel CXCR5 regulatory element by reporter assay, in vivo viral infection models\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct binding to CXCR5 regulatory element combined with in vivo KO phenotype\",\n      \"pmids\": [\"30971440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BACH2 in resting Treg cells binds to enhancers of genes involved in activated Treg differentiation and represses their TCR-driven induction by competing with AP-1 factors for DNA binding, thereby maintaining Treg quiescence.\",\n      \"method\": \"Bach2 conditional KO in Tregs, ChIP-seq, ATAC-seq, tumor immunosuppression models\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq and ATAC-seq combined with conditional KO and AP-1 competition mechanistic evidence\",\n      \"pmids\": [\"32515782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BACH2 counteracts the DNA-binding activity of IRF4 and limits chromatin accessibility, thereby attenuating IRF4-dependent transcription in Treg cells. Loss of Bach2 normalizes eTreg differentiation of IRF4-deficient Tregs, establishing genetic epistasis between BACH2 and IRF4.\",\n      \"method\": \"Bach2/IRF4 double conditional KO epistasis experiments, ATAC-seq, ChIP-seq\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double KO combined with chromatin accessibility profiling\",\n      \"pmids\": [\"31937752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BACH2 establishes the transcriptional and epigenetic programs of stem-like CD8+ T cells during chronic infection; BACH2 overexpression enforces stem-like cell fate while BACH2 deficiency impairs stem-like CD8+ T cell differentiation. BACH2 suppresses the terminal exhaustion program through transcriptional repression and epigenetic silencing.\",\n      \"method\": \"BACH2 KO, overexpression, single-cell transcriptomics, single-cell epigenomics (scATAC-seq), chronic viral infection models\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-cell multi-omic approaches combined with KO and overexpression in vivo\",\n      \"pmids\": [\"33574619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BACH2 directly represses CD25 (IL-2Rα) transcription in Treg cells, thereby attenuating IL-2R signaling. Upregulated CD25/IL-2R signaling in Bach2-deficient resting Tregs partially counteracts poor survival. Bach2 also suppresses CD25/IL-2R signaling in T follicular regulatory cells to enable their full differentiation.\",\n      \"method\": \"Bach2 conditional KO in Tregs, ChIP at CD25 locus, flow cytometry, in vivo Tfr analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct BACH2 repression of CD25 combined with conditional KO functional data\",\n      \"pmids\": [\"33979619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BACH2 knockdown in T2D pancreatic islets reverses cellular features of the disease, restoring a non-diabetic phenotype. BACH2 is identified as a master regulator of T2D islet cell states via single-cell gain- and loss-of-function analyses and glucose-induced Ca2+ flux assays.\",\n      \"method\": \"Single-cell gain/loss-of-function, Ca2+ flux assays, BACH2 KO in T2D islets, BACH inhibitor treatment in diabetic mice and human islets\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in primary human islets and mouse models; single lab\",\n      \"pmids\": [\"34907913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BACH2 acts as an intrinsic negative regulator of NK cell maturation and function by restricting maturation in the presence of weak stimulatory signals. BACH2 expression positively correlates with TCF1 and negatively correlates with NK effector molecules; lack of BACH2 causes changes in chromatin accessibility and accumulation of activated, terminally differentiated NK cells with augmented anti-tumor cytotoxicity.\",\n      \"method\": \"Bach2 conditional KO in NK cells, ATAC-seq, flow cytometry, tumor metastasis models\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with ATAC-seq and in vivo tumor metastasis functional readout\",\n      \"pmids\": [\"36178457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BACH2 regulates apoptosis in pancreatic β-cells via JNK1 modulation: BACH2 inhibition exacerbates cytokine-induced β-cell apoptosis via the mitochondrial pathway by upregulating MKK7 and downregulating PTPN2, leading to increased JNK1 and BIM phosphorylation.\",\n      \"method\": \"BACH2 siRNA knockdown and overexpression in human and rodent β-cells, kinase activity assays, apoptosis assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — siRNA and overexpression with epistasis knockdowns of JNK1/BIM; single lab\",\n      \"pmids\": [\"24608439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Bach2 directly represses the AP-1-driven induction of the interleukin-2 gene in CD4+ T cells by binding to multiple MARE-like sites on the IL-2 proximal promoter in a manner competitive with AP-1 factors.\",\n      \"method\": \"Luciferase reporter assay, ChIP, BACH2 overexpression and knockdown in primary and transformed CD4+ T cells\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — ChIP and reporter assay with overexpression/knockdown; limited to single lab\",\n      \"pmids\": [\"28855027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bach2 promotes BCR-induced B-cell proliferation and survival by repressing cyclin-dependent kinase inhibitors (Cdkn1a, Cdkn2a, Cdkn2b) and maintaining expression of anti-apoptotic Bcl-xL. ChIP showed direct binding of Bach2 to CKI family gene loci.\",\n      \"method\": \"Bach2 KO mice, BrdU incorporation, ChIP, transcriptome analysis, Bcl-xL reconstitution\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct binding plus KO mouse with reconstitution experiment\",\n      \"pmids\": [\"29540581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The relative strength of BLIMP1 versus BACH2 progressively increases in favor of BLIMP1 in antigen-responding B cells through primary responses, with epigenetic imprinting driven by IRF4 determining MBC fate upon recall. Skewing the BLIMP1-BACH2 balance in fate-predisposed MBC subsets can switch their fate preferences.\",\n      \"method\": \"Single-cell epigenomics, ATAC-seq, genetic manipulation of BLIMP1-BACH2 balance in MBC subsets, history-stamped GC B cell analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-cell multi-omic approaches with genetic fate-switching experiments\",\n      \"pmids\": [\"38969872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BACH2 promotes immunomodulatory non-pathogenic TH17 programs and restrains proinflammatory TH1-like programs in TH17 cells. BACH2 establishes distinct chromatin landscapes in npTH17 versus pTH17 cells in vitro and in vivo, sharing accessible chromatin configurations with Treg cells in npTH17 cells.\",\n      \"method\": \"scATAC-seq, scRNA-seq, Bach2 KO in TH17 cells, in vitro and in vivo inflammatory disease models\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-cell chromatin and transcriptome profiling combined with genetic KO in multiple systems\",\n      \"pmids\": [\"39009838\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BACH2 is a BTB-bZIP transcriptional repressor that, as a heterodimer with small Maf proteins or as a competing factor against AP-1/IRF4/BCL6 complexes at enhancers and promoters, suppresses effector differentiation programs in B cells (repressing Blimp-1/Prdm1 to enable CSR/SHM), CD4+ and CD8+ T cells (maintaining naive/regulatory states and preventing terminal differentiation), and innate lymphocytes (NK cells); its activity and subcellular localization are dynamically regulated by PI3K-Akt-mTORC1-mediated phosphorylation (at Ser-535 in mice), SENP3-mediated deSUMOylation (controlling nuclear retention), oxidative-stress-driven inhibition of CRM1-dependent nuclear export, and heme binding to an intrinsically disordered Cys-Pro-rich domain that inhibits DNA binding and promotes degradation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BACH2 is a BTB-bZIP transcriptional repressor that functions as a master regulator of lymphoid and hematopoietic cell fate by suppressing effector differentiation programs across multiple immune lineages. It heterodimerizes with small Maf proteins (e.g., MafK) and binds MARE sequences at enhancers and promoters to repress key targets including PRDM1/Blimp-1, thereby creating a temporal window for class switch recombination and somatic hypermutation in B cells, maintaining naive and regulatory states in CD4+ and CD8+ T cells, restraining NK cell maturation, and promoting lymphoid over myeloid commitment in hematopoietic progenitors [PMID:9755173, PMID:15152264, PMID:23728300, PMID:22194330, PMID:36178457, PMID:25344725]. BACH2 achieves transcriptional repression by recruiting HDAC3-containing NCoR/SMRT co-repressor complexes and by competing with AP-1 (Jun/Batf) and IRF4 at shared enhancer elements, limiting chromatin accessibility for signal-dependent effector gene activation [PMID:26786103, PMID:27581382, PMID:27158840, PMID:31937752]. Its nuclear activity is dynamically regulated: PI3K-Akt-mTORC1-mediated phosphorylation at Ser-535 promotes cytoplasmic retention, SENP3-mediated deSUMOylation prevents nuclear export, oxidative stress inhibits CRM1-dependent export to enforce nuclear accumulation, and heme binding to an intrinsically disordered Cys-Pro-rich region inhibits DNA binding and accelerates degradation [PMID:26620562, PMID:30089837, PMID:10809773, PMID:25444856]. Heterozygous loss-of-function mutations in BACH2 cause BACH2-related immunodeficiency and autoimmunity (BRIDA) in humans [PMID:28530713].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of BACH2 as a B-cell transcriptional repressor that heterodimerizes with small Maf proteins and binds MARE elements established the foundational molecular framework for understanding its repressive function.\",\n      \"evidence\": \"Co-IP, EMSA, and reporter assays in B-cell extracts identifying MafK heterodimerization and SMRT co-repressor binding\",\n      \"pmids\": [\"9755173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of co-repressor complexes unknown\", \"Genome-wide binding sites not mapped\", \"Regulation of BACH2 activity not understood\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that BACH2 undergoes CRM1-dependent nuclear export regulated by oxidative stress revealed the first mechanism controlling its subcellular localization and thus repressor activity.\",\n      \"evidence\": \"Leptomycin B treatment, CLS mutagenesis, and fluorescence microscopy showing oxidative stress blocks nuclear export\",\n      \"pmids\": [\"10809773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of reactive cysteines mediating redox sensitivity not defined\", \"Physiological oxidative stimuli in immune cells not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstration that oxidative stress drives BACH2 to PML nuclear body-associated foci and promotes apoptosis linked its redox-sensitive localization to a functional cellular outcome.\",\n      \"evidence\": \"Immunofluorescence co-localization with PML bodies and apoptosis assays in retroviral expression system\",\n      \"pmids\": [\"11923289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PML body association is required for apoptosis not resolved\", \"Relevance to primary B cells not established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genetic ablation of Bach2 proved it is essential for class switch recombination and somatic hypermutation, establishing BACH2 as a central regulator of B-cell diversification rather than merely a repressor of individual genes.\",\n      \"evidence\": \"Bach2 knockout mice with in vitro B-cell stimulation and immunoglobulin analysis\",\n      \"pmids\": [\"15152264\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes mediating CSR/SHM requirement unknown\", \"Mechanism linking BACH2 to AID regulation not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery of BACH2 SUMOylation and its requirement for PML body recruitment, together with the BTB domain's role in focus formation and rapid dynamic turnover, defined how post-translational modification and oligomerization organize BACH2 into functional nuclear compartments.\",\n      \"evidence\": \"FRAP, sumoylation assays, BTB mutagenesis, and reporter assays\",\n      \"pmids\": [\"15060166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SUMO site identity not mapped\", \"Whether SUMOylation affects DNA-binding activity not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of PRDM1/Blimp-1 as a direct BACH2 target gene provided the key mechanistic link explaining how BACH2 delays plasma cell differentiation and enables CSR.\",\n      \"evidence\": \"EMSA, ChIP at PRDM1 MARE, reporter assays, and shRNA knockdown in primary Bach2-deficient B cells\",\n      \"pmids\": [\"17046816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PRDM1 repression alone accounts for CSR rescue not tested\", \"Genome-wide target repertoire not yet mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that BCR/ABL-driven PI3K/S6K signaling phosphorylates BACH2 at S521 to promote cytoplasmic retention established that oncogenic signaling inactivates BACH2 by controlling its localization.\",\n      \"evidence\": \"Site-directed mutagenesis, phosphorylation assays, subcellular fractionation in CML cells\",\n      \"pmids\": [\"17018862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this mechanism operates in normal B cells not shown\", \"Identity of kinase directly phosphorylating S521 not fully resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genetic epistasis showing that loss of Blimp-1 in Bach2-null B cells restores CSR proved that BACH2 acts upstream of Blimp-1 in the B-cell gene regulatory network, and that the CSR defect is due to premature Blimp-1 derepression.\",\n      \"evidence\": \"Bach2/Prdm1 double-knockout mice with mathematical modeling of the GRN\",\n      \"pmids\": [\"20953163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Additional BACH2 targets contributing to GC B-cell program not fully defined\", \"Whether time-delay model applies across all CSR isotypes not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Biochemical and structural characterization showed heme binds BACH2 to inhibit DNA binding and reduce protein stability, and the BTB domain crystal structure revealed a disulfide-linked homodimer, defining two key regulatory inputs and the structural basis for dimerization.\",\n      \"evidence\": \"In vitro heme-binding assays, pulse-chase stability assays, X-ray crystallography at 2.1 Å\",\n      \"pmids\": [\"21444915\", \"22194330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological heme concentrations in B cells during differentiation not measured\", \"How heme binding is coordinated with phosphorylation/SUMO signals unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A transformative set of studies extended BACH2's role beyond B cells: it was shown to broadly repress effector CD4+ T-cell programs (Th1/Th2/Th17), promote Foxp3+ Treg formation, maintain naive T-cell identity, activate p53 for pre-B cell negative selection, and cooperate with BCL6 genome-wide in GC B cells.\",\n      \"evidence\": \"Bach2 KO mice with ChIP-seq, genome-wide expression profiling, Treg transfer, pre-B cell leukemia models, and BCL6 co-occupancy analysis\",\n      \"pmids\": [\"23728300\", \"23754397\", \"23852341\", \"24277074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BACH2 and BCL6 form a physical complex on chromatin not established by ChIP-seq alone\", \"Mechanism by which BACH2 promotes Foxp3 transcription versus repressing competitors not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"BACH2 was shown to repress myeloid genes in common lymphoid progenitors to enforce B-cell lineage commitment and to promote erythroid over myeloid fate at the erythro-myeloid bifurcation, establishing BACH2 as a hematopoietic lineage decision factor beyond adaptive immunity.\",\n      \"evidence\": \"Bach2/Bach1 KO mice, single-cell CLP analysis, human CD34+ HSPC knockdown, ChIP at myeloid gene loci\",\n      \"pmids\": [\"25344725\", \"30250186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of BACH1 versus BACH2 at overlapping targets not delineated\", \"Whether BACH2 directly represses myeloid TFs or acts through Cebpb alone not fully resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of mTORC1 as the kinase directly phosphorylating BACH2 at Ser-535, with this single site being critical for cytoplasmic retention, unified the PI3K-Akt-mTOR signaling axis as the major pathway controlling BACH2 nuclear activity.\",\n      \"evidence\": \"Mass spectrometry phosphosite mapping, in vitro mTORC1 kinase assay, S535A mutagenesis in B cells\",\n      \"pmids\": [\"26620562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional kinases phosphorylate other functionally relevant sites not fully explored\", \"Phosphatase responsible for BACH2 dephosphorylation unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Multiple studies defined BACH2's mechanism in CD8+ T cells and Tregs: it occupies enhancers to compete with AP-1 factors at TCR-responsive elements, recruits HDAC3/NCoR co-repressor complexes to write repressive chromatin marks, and its haploinsufficiency causes human immunodeficiency (BRIDA).\",\n      \"evidence\": \"ChIP-seq/ATAC-seq in CD8+ T cells, mass spectrometry of BACH2 complex identifying HDAC3/NCoR/Rif1, and human genetics with protein stability assays\",\n      \"pmids\": [\"27158840\", \"26786103\", \"28530713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for AP-1 competition not resolved\", \"BRIDA genotype-phenotype spectrum not fully characterized\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstration that BACH2-Batf heterodimers antagonize Batf-IRF4 complexes at AP-1 motifs in Th2 loci provided a specific molecular mechanism by which BACH2 competes for enhancer access with signal-dependent activating complexes.\",\n      \"evidence\": \"Co-IP, ChIP-seq, Bach2 KO mice with cytokine measurement\",\n      \"pmids\": [\"27581382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of BACH2-Batf versus Batf-IRF4 complexes not measured\", \"Whether BACH2-Batf heterodimer has distinct DNA-binding specificity from BACH2-MafK not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The mTORC1/mTORC2 dual regulation of BACH2 (protein localization via mTORC1, mRNA expression via mTORC2-FoxO1) and the identification of BACH2-C/EBPβ mutual repression expanded the signaling network controlling BACH2 and its role in myeloid-lymphoid fate balance.\",\n      \"evidence\": \"mTOR inhibitor treatment with Bach2 KO epistasis; ChIP at Ccnd3 and Cebpb loci; LPS challenge experiments\",\n      \"pmids\": [\"28993481\", \"28273455\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mTORC2-FoxO1 regulation of Bach2 is direct or indirect not fully resolved\", \"Kinetics of mTOR-BACH2 axis during in vivo immune responses not measured\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that SENP3-mediated deSUMOylation of BACH2 prevents nuclear export and stabilizes Treg identity revealed a distinct post-translational mechanism (complementary to phosphorylation and heme binding) that controls BACH2 localization in a cell-type-specific manner.\",\n      \"evidence\": \"Treg-specific Senp3 conditional KO, SUMOylation assays, subcellular fractionation, tumor models\",\n      \"pmids\": [\"30089837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of SUMO acceptor lysines on BACH2 not mapped\", \"Whether SENP3 regulation of BACH2 operates in B cells or CD8+ T cells not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Conditional KO studies with ChIP-seq/ATAC-seq in Tregs demonstrated that BACH2 maintains Treg quiescence by competing with AP-1 at enhancers and counteracting IRF4 to limit chromatin accessibility, with genetic epistasis proving BACH2 and IRF4 oppose each other at shared enhancers.\",\n      \"evidence\": \"Bach2 conditional KO and Bach2/IRF4 double conditional KO in Tregs with ATAC-seq and ChIP-seq\",\n      \"pmids\": [\"32515782\", \"31937752\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BACH2-IRF4 competition is resolved quantitatively during Treg activation not modeled\", \"Whether BACH2 directly modifies IRF4 binding or acts indirectly via chromatin state not distinguished\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Single-cell multi-omic profiling during chronic infection showed BACH2 establishes the stem-like CD8+ T-cell transcriptional and epigenetic program, suppressing terminal exhaustion and positioning BACH2 as a central determinant of T-cell longevity during persistent antigen exposure.\",\n      \"evidence\": \"scRNA-seq, scATAC-seq, BACH2 KO and overexpression in chronic viral infection models\",\n      \"pmids\": [\"33574619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of BACH2 in stem-like CD8+ T cells beyond known targets not identified\", \"Whether BACH2 overexpression can rescue exhausted T cells not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extension to innate lymphocytes showed BACH2 restricts NK cell maturation and terminal differentiation, demonstrating that BACH2's role as a brake on effector programs spans both adaptive and innate lymphoid lineages.\",\n      \"evidence\": \"Bach2 conditional KO in NK cells with ATAC-seq and tumor metastasis models\",\n      \"pmids\": [\"36178457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct BACH2 target genes in NK cells not fully catalogued\", \"Whether BACH2 interacts with the same co-repressor complexes in NK cells as in T/B cells unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Single-cell epigenomic studies of memory B-cell fate and TH17 plasticity showed that the BACH2-BLIMP1 balance is epigenetically imprinted by IRF4 during primary responses and that BACH2 establishes distinct chromatin landscapes favoring non-pathogenic TH17 programs, refining the model of BACH2 as an epigenetic gatekeeper.\",\n      \"evidence\": \"scATAC-seq and scRNA-seq in GC/MBC subsets and TH17 cells with genetic manipulation of BACH2-BLIMP1 balance\",\n      \"pmids\": [\"38969872\", \"39009838\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Epigenetic marks directly written or maintained by BACH2-recruited complexes at specific loci not mapped genome-wide\", \"How BACH2 levels are set in individual cells during stochastic fate decisions not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the full structural basis of BACH2-AP-1/IRF4 enhancer competition, the integration of multiple post-translational signals (phosphorylation, SUMOylation, heme, redox) in vivo, and whether BACH2's non-immune roles (e.g., pancreatic β-cells) employ the same co-repressor mechanisms.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length BACH2 structure available\", \"In vivo quantitative dynamics of BACH2 post-translational modifications during immune activation not measured\", \"Mechanism of BACH2 function in pancreatic islets not resolved relative to immune cell mechanism\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 5, 10, 22, 34]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 5, 12, 14, 22, 26, 34, 36]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 35, 39]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 4, 21, 30]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 6, 21]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 12, 14, 22, 25, 34, 36, 39, 44]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 5, 14, 22, 26, 36]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 21, 27]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [22, 36, 43, 44]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [18, 25, 28, 31]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 13, 40]}\n    ],\n    \"complexes\": [\n      \"BACH2-MafK heterodimer\",\n      \"BACH2-HDAC3-NCoR/SMRT co-repressor complex\",\n      \"BACH2-Batf heterodimer\"\n    ],\n    \"partners\": [\n      \"MAFK\",\n      \"NCOR2\",\n      \"HDAC3\",\n      \"HDAC4\",\n      \"BCL6\",\n      \"BATF\",\n      \"RIF1\",\n      \"NCOR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}